Embargoed and Restricted Access

Reason: Under embargo until November 2018. After this date a copy can be supplied under Section 51 (2) of the Australian Copyright Act 1968 by submitting a document delivery request through your library

Ghrelin receptor agonists as novel breast cancer therapeutics

posted on 2017-11-13, 00:41 authored by CHEUK MAN CHERIE AU
The human cell studies and the live mouse studies are intended to provide the information that is needed to apply therapies to treat breast cancer patients, based on our novel discoveries. We believe that des-acyl ghrelin-like compounds will be novel breast cancer therapeutics while avoiding well-documented serious side effects, including joint pain, osteoporosis or endometrial cancer. Our findings could therefore improve the quality of life of women treated for breast cancer, improve compliance and improve survival.


Principal supervisor

Kristy Brown

Additional supervisor 1

John Furness

Year of Award


Department, School or Centre

Clinical Sciences at Monash Health

Additional Institution or Organisation

Obstetrics and Gynaecology

Campus location



Doctor of Philosophy

Degree Type



Faculty of Medicine Nursing and Health Sciences